top of page

【#ARTICLES|#Biomed】 BioXcel Therapeutics Announces FDA Approval of #IGALMI™

對於精神分裂相關疾病困擾提供助益 “There are large numbers of patients who experience agitation associated with schizophrenia and bipolar disorders, and this condition has been a long-standing challenge for healthcare professionals to treat”

多了另一種治療的選擇 “The approval of #IGALMI, a self-administered film with a desirable onset of action, represents a milestone moment. It provides healthcare teams with an innovative tool to help control agitation. As clinicians, we welcome this much-needed new oral treatment option.”


Source |[0]=AT26uptfzRJxyQQhkNGkrgiGUgAnW_eyCif2iDs_uHKCGOIiAQn64t9Jj055maubeT0g1FWRFAmmqwkn-l_EPjMdBa-BW1DH8Nqj15rT7z_BwQa7f5SQe2-a2JRYmE5DXOLrORW79hVdTCR2M39S6utWZeflPIPlfR9oxYru0rCSA-erNOsbXSw6byt_0oHsrFbi8Q

0 views0 comments
bottom of page